Dr. Reddy's Laboratories is currently trading at RS 1240.05, up by 22.90 points or 1.88% from its previous closing of RS 1155.50 on the BSE.

The stock opened at RS 1191.65 and touched a high of RS 1224.25 and a low of RS 1188.95 so far. Nearly 718,493 shares have been traded on the counter.

The BSE Group 'A' stock, with a face value of RS 1, has recorded a 52-week high of RS 1,377.95 on 12-Jun-2025 and a 52-week low of RS 1025.90 on 07-Apr-2025.

During the last one week, the stock has traded between a high of RS 1250.35 and a low of RS 1149.00. The company’s current market capitalization stands at RS 103410.70 crore.

Shareholding data indicates that promoters hold 26.64%, while Institutions and Non-Institutions hold 52.78% and 9.72%, respectively.

On the earnings front, Dr. Reddy’s Laboratories reported an 89.33% decline in standalone net profit at RS 90.60 crore for the quarter ended December 31, 2025, compared to RS 849.40 crore in the same quarter of the previous year. Total income dropped 11.57% to RS 4,643.00 crore in Q3 FY26 from RS 5,250.40 crore a year earlier.

On a consolidated basis, the company posted a 14.42% fall in net profit to RS 1,209.90 crore for Q3 FY26 as against RS 1,413.70 crore a year ago. However, consolidated total income rose 5.75% to RS 9,022.20 crore, compared to RS 8,531.40 crore in the corresponding quarter of the previous year.